Abstract
Study objectives There have been few reports on clinical characteristics of lung cancer patients with previous or simultaneous urologic cancers. Additionally, it was scarcely reported whether these patients could tolerate standard therapy. To evaluate them, we conducted a retrospective study. Methods The records of patients with lung cancer who had previously or simultaneously urological cancers seen in our division between January 1985 and August 2007 were reviewed. Results During the study period, 1,105 patients with lung cancer were seen at our division. Thirteen (1.2%) had previous or simultaneous urological cancers (11 males). Eleven patients were smokers. The diagnosis of urological cancers preceded the diagnosis of lung cancer in all but three patients, for whom the diagnosis of urologic cancers was made during the workup of primary lung cancer. Histologically, the lung cancers included six squamous cell carcinomas, four adenocarcinomas, and three small cell lung cancers. Four underwent surgical resection. Six were treated with platinum-containing chemotherapy, but none of them developed severe renal toxicity. The median survival following the diagnosis of lung carcinoma for NSCLC patients was 18 months, and for SCLC it was 24 months. The cause of death in the 12 patients who died in the study period was directly related to lung cancer, and recurrence of urological cancers was observed in none of the patients. Conclusions For patients with urological cancers, smoking cessation, a chest radiograph or CT scan at least yearly and swift evaluation of signs or symptoms that are suggestive of lung cancer should be recommended.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Liu YY, Chen YM, Yen SH, Tsai CM, Perng RP. Multiple primary malignancies involving lung cancer—clinical characteristics and prognosis. Lung Cancer. 2002;35:189–94.
Hajdu SI, Hajdu EO. Multiple primary malignant tumors. J Am Geriatr Soc. 1968;16:16–26.
Lippman SM, Benner SE, Hong WK. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res. 1994;54(7 Suppl):2025s–28s.
Kuriakose MA, et al. Simultaneously presenting head and neck and lung cancer: a diagnostic and treatment dilemma. Laryngoscope. 2002;112:120–3.
Douglas WG, et al. Current concepts in the management of a second malignancy of the lung in patients with head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2003;11:85–8.
Libby DM, et al. Simultaneous pulmonary and renal malignancy. Chest. 1990;98:153–6.
Massarweh S, Lewitton M, Popat U, Lynch GR. Synchronous renal cell carcinoma and limited-stage small-cell lung cancer. J Clin Oncol. 2003;21:2439–40.
Salminen E, Pukkala E, Teppo L. Bladder cancer and the risk of smoking-related cancers during follow up. J Urol. 1994;152:1420–3.
Skov T, Sprogel P, Engholm G, Frolund C. Cancer of the lung cancer and urinary bladder in Denmark, 1943–87: a cohort analysis. Cancer Causes Control. 1991;2:365–9.
Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumor type. J Intern Med. 2002;252:206–24.
Kantor AF, Mclaughlin JK. Second cancer following cancer of the urinary system in Connecticut, 1935–82. Natl Cancer Inst Monogr. 1985;68:149–59.
Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, T’Mannetje A, Kogevinas M, Boffetta P. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case–control studies. Int J Cancer. 2000;86:289–94.
Brennan P, et al. The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control. 2001;12:411–7.
Ross RK, Paganini-Hill A, Landolph J, Gerkins V, Henderson BE. Analgesics, cigarette smoking, and other risk factors for cancer of the renal pelvis and ureter. Cancer Res. 1989;49:1045–8.
McLaughlin JK, et al. Cigarette smoking and cancers of the renal pelvis and ureter. Cancer Res. 1992;52:254–7.
Greene FL, Page D, Morrow M. AICC cancer staging manual 6th ed. New York: Springer, 2002.
World Health Organizations: Histological typing of lung and pleural tumours. 3rd ed., International histological classification of tumours. Geneva, 1999.
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710–7.
Jett JR, Cortese DA, Fontana RS. Lung cancer: current concepts and prospects. CA Cancer J Clin. 1983;33:74–86.
Risin D, et al. Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine. Cancer Immunol Immunother. 1995;40:57–64.
Bohle A, Rusch-Gerdes S, Ulmer AJ, Braasch H, Jocham D. The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma. J Urol. 1996;155:1892–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyazaki, K., Satoh, H., Kagohashi, K. et al. Lung cancer patients with previous or simultaneous urologic cancers. Med Oncol 25, 443–446 (2008). https://doi.org/10.1007/s12032-008-9063-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9063-1